- Home
- WS vs CLDX Comparison
WS vs CLDX Comparison
Compare WS & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WS
- CLDX
- Stock Information
- Founded
- WS 1955
- CLDX 1983
- Country
- WS United States
- CLDX United States
- Employees
- WS N/A
- CLDX N/A
- Industry
- WS
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- WS
- CLDX Health Care
- Exchange
- WS Nasdaq
- CLDX Nasdaq
- Market Cap
- WS 2.2B
- CLDX 1.8B
- IPO Year
- WS N/A
- CLDX 2008
- Fundamental
- Price
- WS $34.11
- CLDX $25.14
- Analyst Decision
- WS Buy
- CLDX Buy
- Analyst Count
- WS 2
- CLDX 7
- Target Price
- WS $40.00
- CLDX $64.83
- AVG Volume (30 Days)
- WS 393.8K
- CLDX 1.1M
- Earning Date
- WS 12-18-2024
- CLDX 11-06-2024
- Dividend Yield
- WS 1.88%
- CLDX N/A
- EPS Growth
- WS 12.14
- CLDX N/A
- EPS
- WS 2.85
- CLDX N/A
- Revenue
- WS $3,289,800,000.00
- CLDX $9,976,000.00
- Revenue This Year
- WS N/A
- CLDX N/A
- Revenue Next Year
- WS $0.06
- CLDX N/A
- P/E Ratio
- WS $11.97
- CLDX N/A
- Revenue Growth
- WS N/A
- CLDX 128.55
- 52 Week Low
- WS $23.82
- CLDX $22.93
- 52 Week High
- WS $47.19
- CLDX $53.18
- Technical
- Relative Strength Index (RSI)
- WS 26.94
- CLDX 42.64
- Support Level
- WS $30.00
- CLDX $23.94
- Resistance Level
- WS $45.46
- CLDX $26.66
- Average True Range (ATR)
- WS 1.68
- CLDX 1.36
- MACD
- WS -1.42
- CLDX -0.07
- Stochastic Oscillator
- WS 25.20
- CLDX 25.48
About WS Worthington Steel Inc.
Worthington Steel Inc is a processor of carbon flat-rolled steel, a producer of laser-welded solutions, and a provider of electrical steel laminations. The company has manufacturing facilities across the United States, Canada, China, India, Germany and Mexico. It buys coils of steel from primary steel producers and processes them to precise type, thickness, length, width, shape, and surface quality required by customer specifications. The company's product lines and processing capabilities include; carbon flat-rolled steel processing, electrical steel laminations, and tailor welded products. Geographically, the company generates a majority of its revenue from the United States followed by Canada, Mexico, and other regions.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.